Your browser doesn't support javascript.
loading
[Idiopathic mast cell activation syndrome]. / Het idiopathisch mestcelactivatiesyndroom.
van Daele, Paul L A; Hermans, Maud A W; Oude Elberink, J Hanneke N G; van Wijk, Roy Gerth.
Afiliación
  • van Daele PLA; Erasmus MC, afd. Interne Geneeskunde, sectie Allergologie-Klinische Immunologie, Rotterdam.
  • Hermans MAW; Contact: Paul L.A. van Daele (p.l.a.vandaele@erasmusmc.nl).
  • Oude Elberink JHNG; Erasmus MC, afd. Interne Geneeskunde, sectie Allergologie-Klinische Immunologie, Rotterdam.
  • van Wijk RG; UMCG, afd. Allergologie, Groningen.
Ned Tijdschr Geneeskd ; 1662022 01 24.
Article en Nl | MEDLINE | ID: mdl-35129899
BACKGROUND: Idiopathic mast cell activation syndrome (MCAS) is one of the causes for recurrent complaints. The diagnosis is sometimes delayed but also often made incorrectly. CASE: Our patient presented with recurrent attacks of itching, redness of the skin, diarrhea and near collapse. During an attack his serum tryptase level rose significantly. We could not identify an underlying trigger. A diagnosis of idiopathic mast cell activation syndrome was made. He was successfully treated with a combination of H1 and H2 blockade. CONCLUSION: MCAS is characterized by recurrent complaints. To make the diagnosis a significant rise in mast cell mediators is required. Given the diversity of symptoms many patients with somatically unexplained symptoms wrongfully believe to be suffering from MCAS.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mastocitosis / Síndrome de Activación de Mastocitos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans / Male Idioma: Nl Revista: Ned Tijdschr Geneeskd Año: 2022 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mastocitosis / Síndrome de Activación de Mastocitos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans / Male Idioma: Nl Revista: Ned Tijdschr Geneeskd Año: 2022 Tipo del documento: Article